2012•The LancetOpen access

Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial

Winette T.A. van der Graaf, Jean‐Yves Blay, Sant P. Chawla, Dong‐Wan Kim, B. Bui-Nguyen, Paolo G. Casali, Patrick Schöffski, Massimo Aglietta, Arthur P. Staddon, Yasuo Beppu, Axel Le Cesne, Hans Gelderblom, Ian Judson, Nobuhito Araki, M. Ouali, Sandrine Marréaud, Rachel Hodge, Mohammed R Dewji, Corneel Coens, George D. Demetri, Christopher D.�M. Fletcher, Angelo Paolo Dei Tos, Peter Hohenberger

Open full text 2,112 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 2112 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Pazopanib, Placebo, Soft tissue sarcoma, Medicine, Sarcoma, Soft tissue, Palette (painting), Oncology